Top Markets
#1 Siren Siren +38.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.79%
#3 RedStone RedStone +18.90%
#4 Verus Coin Verus Coin +18.06%
#5 Ocean Protocol Ocean Protocol +15.61%
#6 Cysic Cysic +15.47%
#7 OpenEden OpenEden +14.56%
#8 Perle Perle +12.68%
#9 KUB Coin KUB Coin +12.53%
#10 Arowana Arowana +11.84%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Makers Laboratories Limited Makers Laboratories Limited

Makers Laboratories Limited

MAKERSL
Rank in Stocks #32333
Makers Laboratories Ltd. functions as a pharmaceutical company, primarily... Makers Laboratories Ltd. functions as a pharmaceutical company, primarily focused on the creation, production, and sale of medicinal products. Its array of proprietary formulations features prominent brands like Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin. Established on July 9, 1984, the firm's main corporate office is situated in Mumbai, India.
Share Price
$1.78
Market Cap
$10.48M
Change (1 day)
2.88%
Change (1 year)
4.77%
Country
IN
Trade Makers Laboratories Limited (MAKERSL)

Category

Healthcare
P/S ratio for Makers Laboratories Limited (MAKERSL)
P/S ratio as of 2026 TTM: 0
According to Makers Laboratories Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Makers Laboratories Limited from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US